Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback